Evidence map›Paper›PMID 39478329›Full record

ArticleCannabis and cannabinoid research2025

Minor Cannabinoid Profile of Unregulated Cannabidiol Products.

Erin Johnson, Michael Kilgore, Paul Nuzzo, Shanna Babalonis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cannabis and cannabinoid research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Erin JohnsonLGC Assure, Lexington, Kentucky, USA.
Michael KilgoreCollege of Medicine, Department of Pharmacology and Nutritional Science, University of Kentucky, Lexington, Kentucky, USA.
Paul NuzzoCollege of Medicine, Center on Drug and Alcohol Research, Cannabis Center, University of Kentucky, Lexington, Kentucky, USA.
Shanna BabalonisCollege of Medicine, Center on Drug and Alcohol Research, Cannabis Center, University of Kentucky, Lexington, Kentucky, USA.ORCID 0000-0002-1450-2621

Funding

Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Opioid Abuse Potential and Opioid SafetyR01DA054347 · NIDA · UNIVERSITY OF KENTUCKY · PI Shanna Babalonis · 2022 to 2026
$2.8M
Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug IntakeR01DA045700 · NIDA · UNIVERSITY OF KENTUCKY · PI BABALONIS, SHANNA · 2018 to 2021
$2.3M
NIDA NIH HHS R01 DA045700NIDA NIH HHS R01 DA054347
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolCannabinoidsCannabisChromatography, LiquidCross-Sectional StudiesKentuckyTandem Mass SpectrometryCannabidiolCannabinoidsanalytical chemistrycannabidiolCBDminor cannabinoidsregulation

Identifiers

PMID39478329
PMCPMC13624896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.